A Japanese multinational biopharma, focused on innovative therapies for oncology, auto-immune diseases, neurology, and rare conditions, partnered with Indegene to predict chronic kidney disease (CKD) diagnosis and prognosis using real-world data (RWD). Facing challenges in identifying predictive variables and lacking standardized data management, cleaning, analysis, reporting, and visualization processes, Indegene's AI/ML-powered software transformed RWD into actionable insights. Subject matter experts established precise risk predictors, diagnosis criteria, disease stages, and progression models through comprehensive research—enabling standardized workflows, accurate predictions, and accelerated innovation to address unmet CKD needs efficiently.

Join for free to read